• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

Global and regional estimates of the contribution of herpes simplex virus type 2 infection to HIV incidence

byArnav Agarwal, MD
December 16, 2019
in Infectious Disease, Public Health
Reading Time: 1 min read
0
Share on FacebookShare on Twitter

1. Herpes simplex virus type 2 (HSV-2) infections significantly contribute to the global burden of sexually-acquired HIV infections.

Evidence Rating Level: 2 (Good)

There is a known strong biological association between herpes simplex virus type 2 (HSV-2) and human immunodeficiency virus (HIV) acquisition, transmissibility, and disease severity. This analysis provides the first global and regional-level analysis of population attributable fractions (PAFs) and incidence of HIV infections attributable to HSV-2 infection, with subgroup analyses for female sex workers (FSWs) and men who have sex with men (MSM). Classic epidemiological statistics of polytomous exposure to estimate global and regional PAF and incident HIV infections by age, sex and timing, with pooled adjusted relative risk estimates from systematic review data were used to analyze the association of HSV-2 infection on HIV acquisition. Analyses revealed that 420,000 (95% CI 317,000 to 546,000; PAF 29.6% [95% CI 22.9 to 37.1]) of 1.4 million sexually-acquired adult HIV infections in 2016 were attributable to HSV-2 infections. The largest contribution of HSV-2 infections was evident in the African region, among women, those aged 25 to 49 years, and those with established HSV-2 infections. Study findings suggest a significant burden of underlying HSV-2 infections in sexually-transmitted HIV acquisition, with the greatest burden of HSV-2 infections in areas where the infection is most prevalent.

Click to read the study in Lancet Infectious Diseases

Image: PD

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Anal cancer screening cost-effective for men who have sex with men with human immunodeficiency virus aged above 35 years

Oral gepotidacin is non-inferior to standard therapy for uncomplicated urogenital gonorrhea

Safety of investigational vaccines against human immunodeficiency virus

Tags: herpes simplex virus (HSV)human immunodeficiency virus (HIV)sexually transmitted infection (STI)
Previous Post

More than half of pediatric residents meet criteria for burnout

Next Post

Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants

RelatedReports

Government-funded initiatives provide important supports to low-income HIV patients
Infectious Disease

Anal cancer screening cost-effective for men who have sex with men with human immunodeficiency virus aged above 35 years

June 16, 2025
Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization
Infectious Disease

Oral gepotidacin is non-inferior to standard therapy for uncomplicated urogenital gonorrhea

May 28, 2025
Combined immunotherapy may improve survival in metastatic pancreatic cancer
Infectious Disease

Safety of investigational vaccines against human immunodeficiency virus

April 29, 2025
#VisualAbstract: Doxycycline Post-Exposure Prophylaxis Effectively Prevents Bacterial Sexually Transmitted Infections
StudyGraphics

#VisualAbstract: Doxycycline Post-Exposure Prophylaxis Effectively Prevents Bacterial Sexually Transmitted Infections

April 9, 2025
Next Post
Quick Take: Continuous low-dose antibiotic prophylaxis for adults with repeated urinary tract infection (AnTIC)

Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants

#VisualAbstract: Prevention of Early Ventilator-Associated Pneumonia after Cardiac Arrest

#VisualAbstract: Prevention of Early Ventilator-Associated Pneumonia after Cardiac Arrest

Publication of pneumonia antibiotic guidelines changed prescribing trends

Long-term impact of an educational antimicrobial stewardship programme in primary care on infections caused by extended-spectrum β-lactamase-producing Escherichia coli in the community

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Obicetrapib Reduced LDL Cholesterol in Patients at High Cardiovascular Risk
  • St. Louis hospital-based violence intervention program did not significantly affect reinjury outcomes
  • Glucagon-like peptide-1 receptor agonists may increase risk of reflux in patients with type 2 diabetes
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.